You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CHLORPROTHIXENE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for chlorprothixene and what is the scope of freedom to operate?

Chlorprothixene is the generic ingredient in one branded drug marketed by Roche and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for CHLORPROTHIXENE
US Patents:0
Tradenames:1
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 62
Clinical Trials: 3
Patent Applications: 6,901
DailyMed Link:CHLORPROTHIXENE at DailyMed
Recent Clinical Trials for CHLORPROTHIXENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hannover Medical SchoolPhase 3
Canadian Institutes of Health Research (CIHR)
Canadian Network for Observational Drug Effect Studies, CNODES

See all CHLORPROTHIXENE clinical trials

Medical Subject Heading (MeSH) Categories for CHLORPROTHIXENE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPROTHIXENE

US Patents and Regulatory Information for CHLORPROTHIXENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche TARACTAN chlorprothixene CONCENTRATE;ORAL 016149-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TARACTAN chlorprothixene INJECTABLE;INJECTION 012487-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.